IMARC Group's report titled "Ureteral Stents Market Report by Product Type (Open-End Stents, Closed-End Stents, Double J-Stent, Multiloop Stents), Material (Metallic Ureteral Stents, Polymer Ureteral Stents), Application (Kidney Stones, Kidney Transplantation, Tumors, Urinary Incontinence, and Others), End Use (Hospitals and Clinics, Ambulatory Surgical Centers (ASCs), and Others), and Region 2024-2032",The global ureteral stents market size reached US$ 374.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 606.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. 

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/ureteral-stents-market/requestsample

Factors Affecting the Growth of the Ureteral Stents Industry:

• Prevalence of Urological Disorders:

Urological disorders, such as kidney stones, are becoming more prevalent globally due to factors like changes in dietary habits, sedentary lifestyles, and dehydration. Kidney stones can cause severe pain and urinary obstruction, often requiring medical intervention. Ureteral stents are commonly used in the management of kidney stones, either as a temporary measure to relieve obstruction or as a post-surgical aid to facilitate drainage and promote healing. UTIs are a common urological problem, especially in women. In some cases, UTIs can lead to urinary obstruction, necessitating the placement of ureteral stents to maintain urinary flow and prevent complications.

• Technological Advancements:

Innovations in stent design are leading to the development of stents with enhanced features, such as improved flexibility, better conformability to the urinary tract anatomy, and reduced encrustation. These design improvements aim to minimize patient discomfort, reduce the risk of complications, and optimize stent performance. The use of biocompatible materials in stent manufacturing helps reduce the risk of adverse reactions and tissue irritation. Innovations in materials science are leading to the introduction of stents made from materials like silicone, hydrogels, and advanced polymers, which offer better biocompatibility and minimize the body's immune response to the stent.

• Aging Population:

Aging is associated with a higher prevalence of urological disorders, such as kidney stones, urinary tract infections (UTIs), benign prostatic hyperplasia (BPH), and urinary incontinence. As individuals are aging, the risk of developing these conditions is increasing, leading to greater demand for medical interventions, including the use of ureteral stents. Aging is often accompanied by structural changes in the urinary tract, such as decreased bladder compliance, urethral sphincter dysfunction, and prostate enlargement (in men). These changes can predispose older adults to urinary tract obstructions and urinary retention, necessitating the placement of ureteral stents to restore urinary flow and alleviate symptoms.

Leading Companies Operating in the Global Ureteral Stents Industry:

• Allium Medical Solutions Ltd.
• B. Braun Melsungen AG
• Biomerics
• Boston Scientific Corporation
• Becton, Dickinson and Company
• Coloplast Ltd.
• Cook Group Incorporated
• Medline Industries Inc.
• Merit Medical Systems Inc.
• Olympus Corporation
• Teleflex Incorporated

Ureteral Stents Market Report Segmentation:

By Product Type:

• Open End Stents
• Closed End Stents
• Double J-Stent
• Multiloop Stents

Double J-stents represent the largest segment due to their widespread use in managing various urological conditions, offering effective drainage, reduced risk of migration, and improved patient comfort compared to other types of stents.

By Material:

• Metallic Ureteral Stents
• Polymer Ureteral Stents
  • Silicone Stents
  • Polyurethane Stents
  • Hybrid Stents

Polymer ureteral stents account for the majority of the market share owing to their favorable characteristics, such as biocompatibility, flexibility, and reduced encrustation rates, addressing key challenges associated with metal or silicone stents.

By Application:

• Kidney Stones
• Kidney Transplantation
• Tumors
• Urinary Incontinence
• Others

Kidney stones exhibit a clear dominance in the market driven by the high prevalence of nephrolithiasis globally, necessitating the frequent use of ureteral stents for relieving obstruction, facilitating stone passage, and preventing complications.

By Application:

• Kidney Stones
• Kidney Transplantation
• Tumors
• Urinary Incontinence
• Others

Hospitals and clinics hold the biggest market share as they are primary healthcare facilities where most urological procedures, including ureteral stent placements, are performed, catering to a wide range of patients with urological conditions.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys the leading position in the ureteral stents market on account of the high prevalence of urological disorders, advanced healthcare infrastructure, favorable reimbursement policies, and extensive adoption of minimally invasive urological procedures in the region.

Global Ureteral Stents Market Trends:

Increasing awareness among patients and healthcare providers about the benefits of minimally invasive urological procedures is fueling the demand for ureteral stents, which play a crucial role in facilitating such procedures. Healthcare systems worldwide are increasingly focusing on value-based care, emphasizing improved patient outcomes and cost-effectiveness. Ureteral stents that offer better patient comfort, reduced complications, and longer durability are gaining preference in this context.

Continued investments in research and development  (R&D) activities by key market players aim to develop stents with enhanced properties, such as better biocompatibility, reduced encrustation, and prolonged patency, driving market innovations and competitiveness.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163